References
- 1. el-Shami K, Griffiths E, Streiff M. Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis and treatment. Oncologist. 2007;12:518-23.
- 2. Chen H, Fritz T, Banga P, Wohns D, Cohle S, Banga S. The search for cryptogenic stroke, a case of marantic endocarditis. Int J Cardiovasc Cerebrovasc Dis. 2014;2:39-43.
- 3. Borowski A, Ghodsizad A, Cohnen M, Gams E. Recurrent embolism in the course of marantic endocarditis. Ann Thorac Surg. 2005;79:2145-7.10.1016/j.athoracsur.2003.12.024
- 4. Llenas-Garcia J, Guerra-Vales JM, Montes-Moreno S, López-Rios F, Castelbón-Fernández FJ, Chimeno-Garcia J. Nonbacterial thrombotic endocarditis: clinicopathologic study of a necropsy series. Rev Esp Cardiol. 2007;60:493-500.
- 5. Gonzales Quintela A, Candela MJ, Vidal C, Roman J, Aramburo P. Non-bacterial thrombotic endocarditis in cancer patients. Acta Cardiol. 1991;46:1-9.
- 6. Goldenberg N, Kahn SR, Solymoss S. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism. J Clin Oncol. 2003;21:4194-9.10.1200/JCO.2003.05.165
- 7. Rao LV. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev 1992;11:249-66.10.1007/BF01307181
- 8. Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002;4:465-73.
- 9. Chaturvedi P, Singh AP, Batra SK. Structure, evolution and biology of MUC4 mucin. FASEB J. 2008;22:966-81.10.1096/fj.07-9673rev
- 10. Varki A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood. 2007;110:1723-9.
- 11. Taccone FS, Jeangette SM, Blecic SA. First-ever stroke as initial presentation of systemic cancer. J Stroke Cerebrovasc Dis. 2008;17:169-74.10.1016/j.jstrokecerebrovasdis.2008.01.007
- 12. Scalia GM, Tandon AK, Robertson JA. Stroke, aortic vegetations and disseminated adenocarcinoma- case of marantic endocarditis. Heart Lung Circ. 2012;21:234-6.10.1016/j.hlc.2011.08.003
- 13. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM. Stroke in patients with cancer: incidence and etiology. Neurology. 2004;62:2025-30.
- 14. Singhal AB, Topcuoglu MA, Buonanno FS. Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study. Stroke. 2002;33:1267-73.
- 15. Hong CT, Tsai LK, Jeng JS. Patterns of acute cerebral infarcts in patients with active malignancy using diffusion-weighted imaging. Cerebrovasc Dis. 2009;28:411-6.10.1159/000235629
- 16. Sturgeon CM, Duffy MJ, Hofmann BR et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical and gastric cancers. Clin Chem. 2010;56:e1-48.
- 17. Uemura J, Kimura K, Sibazaki K, Inoue T, Iguchi Y, Yamashita S. Acute stroke patients have occult malignancy more often than expected. Eur Neurol. 2010;64:140-4.10.1159/000316764
- 18. Bajkó Z, Bălaşa R, Moţăţăianu A et al. Malignant Middle Cerebral Artery Infarction Secondary to Traumatic Bilateral Internal Carotid Artery Dissection. A Case Report. J Crit Care Med. 2016;2:135-41.
- 19. Mohr JP, Thompson JL, Lazar RM et al. A comparison of warfarin and aspirin for prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444-51.
- 20. Lee AY, Levine MN, Baker RI, Bowden C et al. Low-molecularweight heparin versus coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.N Engl J Med. 2003;349:146-53.
- 21. Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis 9thed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e576S-e600s.